References
Parale GP, Baheti NN, Kulkarni PM, et al. Effects of atorvastatin on higher functions. Eur J Clin Pharmacol 2006; 6: 259–65
Tatley M, Savane R. Psychiatric adverse reactions with statins, fibrates and ezetimibe: implication for the use of lipid-lowering agents. Drug Saf 2007; 30: 195–201
Suribhatla S, Dennis MS, Potter JF. A study of statin use in the prevention of cognitive impairment of vascular origin in the UK. J Neurol Sci 2005; 229: 147–50
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tuccori, M., Moretti, U., Lapi, F. et al. Poster Presentations. Drug-Safety 30, 970 (2007). https://doi.org/10.2165/00002018-200730100-00061
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200730100-00061